A Phase 1b, Randomized, Double-Blind, Placebo Controlled, Single-Dose Ranging Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GS-5806 in Subjects < 24 Months of Age [...] (2013–2014)
- Grant type:
- Gilead Clinical Trial
- Researchers:
-
-
- Funded by:
- Gilead Sciences Pty Limited
